Literature DB >> 10953263

Imaging techniques to predict cardiovascular risk.

M V McConnell1.   

Abstract

Conventional cardiovascular imaging, with a focus on identifying flow-limiting stenoses, does not directly image the atherosclerotic lesion. Recent clinical and pathobiologic data indicate that stenosis severity does not dictate cardiovascular risk and that there are functional, structural, and biologic features of atherosclerosis that are associated with cardiovascular events. Imaging technologies, such as ultrasound, light, x-ray, magnetic resonance, and targeted contrast agents, have been developed to characterize directly the atherosclerotic vessel wall. They provide promising approaches to predict cardiovascular risk and facilitate further study of the mechanisms of atherosclerosis progression and its response to therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10953263     DOI: 10.1007/s11886-000-0085-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  54 in total

1.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

Authors:  D A Sipkins; D A Cheresh; M R Kazemi; L M Nevin; M D Bednarski; K C Li
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography.

Authors:  M Stuber; R M Botnar; P G Danias; M V McConnell; K V Kissinger; E K Yucel; W J Manning
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

4.  Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke.

Authors:  A Cohen; C Tzourio; B Bertrand; C Chauvel; M G Bousser; P Amarenco
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

5.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

6.  Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery.

Authors:  A Uehata; E H Lieberman; M D Gerhard; T J Anderson; P Ganz; J F Polak; M A Creager; A C Yeung
Journal:  Vasc Med       Date:  1997       Impact factor: 3.239

7.  Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging.

Authors:  Z A Fayad; V Fuster; J T Fallon; T Jayasundera; S G Worthley; G Helft; J G Aguinaldo; J J Badimon; S K Sharma
Journal:  Circulation       Date:  2000-08-01       Impact factor: 29.690

8.  Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients.

Authors:  R B McCully; V L Roger; D W Mahoney; B L Karon; J K Oh; F A Miller; J B Seward; P A Pellikka
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  Phototherapy of cancer and atheromatous plaque with texaphyrins.

Authors:  K W Woodburn; Q Fan; D Kessel; M Wright; T D Mody; G Hemmi; D Magda; J L Sessler; W C Dow; R A Miller; S W Young
Journal:  J Clin Laser Med Surg       Date:  1996-10

10.  Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.

Authors:  J Narula; A Petrov; C Bianchi; C C Ditlow; B C Lister; J Dilley; I Pieslak; F W Chen; V P Torchilin; B A Khaw
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.